NOTABLE LABS, LTD. Proceeds from Issuance Initial Public Offering
NOTABLE LABS, LTD. reported Proceeds from Issuance Initial Public Offering of $1.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2024-05-15
- NOTABLE LABS, LTD. proceeds from issuance initial public offering for the quarter ending 2023-09-30 was $0.00.
- NOTABLE LABS, LTD. proceeds from issuance initial public offering for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- NOTABLE LABS, LTD. proceeds from issuance initial public offering for the quarter ending 2021-12-31 was $196.00K, a 59.59% decline year-over-year.
- NOTABLE LABS, LTD. proceeds from issuance initial public offering for the quarter ending 2021-09-30 was $1.04M.
- NOTABLE LABS, LTD. proceeds from issuance initial public offering for fiscal 2022 was $22.00K, a 99.93% decline from fiscal 2021.
- NOTABLE LABS, LTD. proceeds from issuance initial public offering for fiscal 2021 was $33.16M.
| Period end | Proceeds from Issuance Initial Public Offering | Proceeds from Issuance Initial Public Offering 3 month | Proceeds from Issuance Initial Public Offering 3 month as first filed | Proceeds from Issuance Initial Public Offering 6 month | Proceeds from Issuance Initial Public Offering 9 month | Proceeds from Issuance Initial Public Offering 12 month | Proceeds from Issuance Initial Public Offering 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.00K 10-Q · filed 2023-11-14 | |||||
| 2023-06-30 | $1.00K 10-Q · filed 2023-08-14 | ||||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $22.00K 10-K · filed 2023-03-14 | |||||
| 2022-09-30 | $22.00K 10-Q · filed 2023-11-14 | ||||||
| 2021-12-31 | $196.00K derived: 10-K 12 month − 6-K 9 month · filed 2023-03-14 | $1.23M derived: sum of 2 quarters · filed 2023-03-14 | $29.56M derived: sum of 3 quarters · filed 2023-03-14 | $33.16M 10-K · filed 2023-03-14 | |||
| 2021-10-31 | $1.50M 10-Q · filed 2024-05-15 | ||||||
| 2021-09-30 | $1.04M derived: 6-K 9 month − 6-K 6 month · filed 2022-11-14 | $29.36M derived: sum of 2 quarters · filed 2022-11-14 | $32.96M 6-K · filed 2022-11-14 | $33.44M derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $28.33M derived: 6-K 6 month − 6-K 3 month · filed 2022-08-15 | $31.92M 6-K · filed 2022-08-15 | $32.41M derived: sum of 3 quarters · filed 2022-08-15 | $32.41M derived: sum of 4 quarters · filed 2022-08-15 | |||
| 2021-03-31 | $3.59M 6-K · filed 2022-05-17 | $3.54M 6-K · filed 2021-05-11 | $4.08M derived: sum of 2 quarters · filed 2022-05-17 | $4.08M derived: sum of 3 quarters · filed 2022-05-17 | $22.27M derived: sum of 4 quarters · filed 2022-05-17 | ||
| 2020-12-31 | $485.00K derived: 20-F 12 month − 6-K 9 month · filed 2022-03-23 | $485.00K derived: sum of 2 quarters · filed 2022-03-23 | $18.68M derived: sum of 3 quarters · filed 2022-03-23 | $19.13M 20-F · filed 2022-03-23 | $17.46M 20-F · filed 2021-03-25 | ||
| 2020-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2021-11-15 | $18.19M derived: sum of 2 quarters · filed 2021-11-15 | $18.65M 6-K · filed 2021-11-15 | ||||
| 2020-06-30 | $18.19M derived: 6-K 6 month − 6-K 3 month · filed 2021-08-16 | $18.65M 6-K · filed 2021-08-16 | |||||
| 2020-03-31 | $456.00K 6-K · filed 2021-05-11 | ||||||
| 2019-12-31 | $2.00K 20-F · filed 2022-03-23 | ||||||
| 2018-12-31 | $13.72M 20-F · filed 2021-03-25 |